🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Multiple Sclerosis (MS) Primary Progressive

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis NCT07477639Phase 1, Phase 28 sites📍 La Jolla📍 Kansas City📍 Rochester Tr1X, Inc. · Tests: TRX319, Bendamustine REAL-MS: Observational Database Study of AHSCT and MS Therapies NCT07899502n/a3 sites📍 London📍 London📍 London Imperial College London · Tests: Autologous haematopoietic stem cell transplantation (AHSCT), High-efficacy disease-modifying therapy (HE-DMT) A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis NCT07067463Phase 376 sites📍 Pheonix📍 Scottsdale📍 West Hollywood Zenas BioPharma (USA), LLC · Tests: Orelabrutinib, Placebo Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) NCT06526364n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: All participants will be asked to provide data and samples for collection and analysis. Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis NCT07587125Phase 11 site📍 Xi'an Xijing Hospital · Tests: S103 cells MS-ResearchBiomarkerS NCT05204459n/a1 site📍 Los Angeles Cedars-Sinai Medical Center "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS NCT07222618n/a1 site📍 San Francisco University of California, San Francisco Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis NCT07426991n/a2 sites📍 Düsseldorf📍 Mönchengladbach Heinrich-Heine University, Duesseldorf · Tests: No Intervention: Observational Cohort Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis NCT05177523n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: MRI, Neurocognitive examination for healthy subjects, blood sampling A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS) NCT07840326Phase 27 sites📍 Tampa📍 Atlanta📍 Stony Brook Sundance Biosciences, Inc. · Tests: SUN-627, Placebo Home Based Functional Balance Intervention for Multiple Sclerosis NCT07355387NA1 site📍 Chicago University of Illinois Chicago · Tests: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibul… A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders NCT06680037Phase 18 sites📍 La Jolla📍 Ann Arbor📍 Omaha TG Therapeutics, Inc. · Tests: Azercabtagene zapreleucel (azer-cel) Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy NCT05359653Phase 1, Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Clemastine Fumarate, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy